Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06526260 · ClinicalTrials.gov registry record · NA

Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth

A NA study of Social Anxiety Disorder, sponsored by Children's Hospital Los Angeles.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06526260 is a NA study of Social Anxiety Disorder that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 80 participants, below the 158-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06526260, a NA study of Social Anxiety Disorder, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear ratings, and participants' awareness and tolerance of the exposure stimuli. * The primary outcome of this study is the mean activation of frontostriatal and prefrontal brain regions to facial stimuli, as measured by Blood Oxygen Level Dependent (BOLD) response, in 4 regions of interest during the magnetic resonance imaging (MRI). * Another primary outcome of the study is to identify networks of regions subserving emotion regulation and attention, as measured by BOLD response of corresponding brain regions. Secondary Outcomes -The secondary outcome of this study is the fear induced by exposure to facial expression stimuli as measured by a 4-point fear scale during the functional magnetic resonance imaging (fMRI) after each block of 10 facial expression stimuli trials. Participants will participate in an interview where they will answer questions both inside and outside of the MRI scan. Participants will be asked to rate on a scale the imagines they see while undergoing MRI scan.

Conditions Studied

Interventions

  • BEHAVIORAL Very Brief Exposure to Facial Expressions

Study Locations (1)

California

  • Children's Hospital Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-08-14
Est. Completion 2026-07
Phase NA

Sponsor

Children's Hospital Los Angeles

119 total trials

What the Registry Record Tells You About NCT06526260

The ClinicalTrials.gov registry entry for NCT06526260 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 158-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (49% lower). The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 1 intervention - of which Very Brief Exposure to Facial Expressions is the first listed.

NCT06526260 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06526260 about?

NCT06526260 is a clinical study titled "Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth". The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear r...

What is the current status of trial NCT06526260?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-08-14. Estimated completion is 2026-07.

What conditions does trial NCT06526260 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT06526260?

The interventions under investigation include: Very Brief Exposure to Facial Expressions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06526260?

This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06526260 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.